Q3 FY26 results: Revenue up 11% YoY to Rs 580 Cr, declares Rs 1 interim dividend

Exceptional itemResults View source PDF Explain this filing

IOLCP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-7.2%Reaction day

₹80.85

prior close

₹79.21

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.5%-6.7% vs market

Pharmaceuticals peers, median of 159sector+0.0%-7.2% vs sector

On the reaction day the stock moved 6.7 pts less than Nifty Microcap 250 and 7.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.2

10m

-4.3

15m

-4.6

30m

-5.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-7.2-0.5-6.7+0.0-7.2

Next day

-7.8-1.0-6.8-0.2-7.6

-7.5-2.5-5.0-1.8-5.7

-7.7-3.2-4.5-2.3-5.4

-8.2-2.2-6.0-2.2-6.0

-8.7-1.9-6.8-1.8-6.9

-9.3-3.5-5.8-2.9-6.4

15d

-11.8-8.8-3.0-6.5-5.3

-11.6-9.3-2.3-6.6-5.0

+3.6-4.5+8.2-3.7+7.3

+34.4+5.4+29.0+2.9+31.5

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Standalone Q3 FY26 revenue rose 10.9% YoY to Rs 580.39 Cr; PAT was flat at Rs 20.58 Cr after a Rs 11.21 Cr exceptional charge for new Labour Codes. Nine month FY26 PAT grew 21.9% to Rs 84.54 Cr on Rs 1,699.61 Cr revenue. Pharma segment drove growth with Rs 356 Cr Q3 revenue. Board declared Rs 1 per share (50 percent) interim dividend; record date Feb 17, 2026. Auditor issued an unmodified limited review opinion.

Likely market impact

Steady revenue growth; exceptional Labour Code charge masked underlying Q3 PAT. Rs 1 interim dividend is positive for shareholders.